Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | 30,000 | reported | 06 Aug 2025 | tx 55+2,055,496−188,526 |
| Washington Prime Group Inc. | 12,060 | reported | 17 May 2016 | tx 5+31,843 |
| Emergent BioSolutions Inc. | 11,296 | reported | 30 Apr 2026 | tx 39+286,228−96,221 |
| CoLucid Pharmaceuticals, Inc. | 0 | reported | 01 Mar 2017 | tx 10+18,554−18,554 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Apr 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 25,344 | 0.00 USD | |
| 30 Apr 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 11,296 | 0.00 USD | deriv |
| 06 Aug 2025 | GRANT_AWARD | Aptevo Therapeutics Inc. | 30,000 | 0.00 USD | deriv |
| 17 Jul 2025 | EXERCISE | Aptevo Therapeutics Inc. | 10 | — | |
| 17 Jul 2025 | EXERCISE | Aptevo Therapeutics Inc. | 10 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 34,403 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 15,824 | 0.00 USD | deriv |
| 02 Mar 2025 | EXERCISE | Aptevo Therapeutics Inc. | 8 | — | |
| 03 Mar 2025 | EXERCISE | Aptevo Therapeutics Inc. | 6 | — | |
| 02 Mar 2025 | EXERCISE | Aptevo Therapeutics Inc. | 8 | 0.00 USD | deriv |
| 03 Mar 2025 | EXERCISE | Aptevo Therapeutics Inc. | 6 | 0.00 USD | deriv |
| 11 Nov 2024 | SALE | Emergent BioSolutions Inc. | 14,287 | 11.97 USD | |
| 17 Jul 2024 | GRANT_AWARD | Aptevo Therapeutics Inc. | 22,325 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 17,430 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 25,748 | 0.00 USD | deriv |
| 02 Mar 2024 | EXERCISE | Aptevo Therapeutics Inc. | 12,917 | — | |
| 03 Mar 2024 | EXERCISE | Aptevo Therapeutics Inc. | 9,584 | — | |
| 03 Mar 2024 | EXERCISE | Aptevo Therapeutics Inc. | 9,584 | 0.00 USD | deriv |
| 02 Mar 2024 | EXERCISE | Aptevo Therapeutics Inc. | 12,917 | 0.00 USD | deriv |
| 28 Jan 2024 | EXERCISE | Aptevo Therapeutics Inc. | 4,792 | — | |
| 28 Jan 2024 | EXERCISE | Aptevo Therapeutics Inc. | 4,792 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Emergent BioSolutions Inc. | 33,847 | 0.00 USD | |
| 03 Mar 2023 | EXERCISE | Aptevo Therapeutics Inc. | 9,582 | — | |
| 03 Mar 2023 | EXERCISE | Aptevo Therapeutics Inc. | 9,582 | 0.00 USD | deriv |
| 03 Mar 2023 | GRANT_AWARD | Aptevo Therapeutics Inc. | 38,750 | 0.00 USD | deriv |